Titre : Esclaves

Esclaves : Questions médicales fréquentes

Termes MeSH sélectionnés :

Leukocyte L1 Antigen Complex
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Esclaves : Questions médicales les plus fréquentes", "headline": "Esclaves : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Esclaves : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-26", "dateModified": "2025-04-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Esclaves" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Personnes", "url": "https://questionsmedicales.fr/mesh/D009272", "about": { "@type": "MedicalCondition", "name": "Personnes", "code": { "@type": "MedicalCode", "code": "D009272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "M01" } } }, "about": { "@type": "MedicalCondition", "name": "Esclaves", "alternateName": "Enslaved Persons", "code": { "@type": "MedicalCode", "code": "D063948", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Mark L Latash", "url": "https://questionsmedicales.fr/author/Mark%20L%20Latash", "affiliation": { "@type": "Organization", "name": "Department of Kinesiology, The Pennsylvania State University, Rec.Hall-267, University Park, PA, 16802, USA. mll11@psu.edu." } }, { "@type": "Person", "name": "Eugene T Richardson", "url": "https://questionsmedicales.fr/author/Eugene%20T%20Richardson", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Momin M Malik", "url": "https://questionsmedicales.fr/author/Momin%20M%20Malik", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "William A Darity", "url": "https://questionsmedicales.fr/author/William%20A%20Darity", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "A Kirsten Mullen", "url": "https://questionsmedicales.fr/author/A%20Kirsten%20Mullen", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Dendritic cells steering antigen and leukocyte traffic in lymph nodes.", "datePublished": "2024-07-12", "url": "https://questionsmedicales.fr/article/38997244", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/1873-3468.14982" } }, { "@type": "ScholarlyArticle", "name": "Advances in desensitization for human leukocyte antigen incompatible kidney transplantation.", "datePublished": "2023-12-14", "url": "https://questionsmedicales.fr/article/38088373", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MOT.0000000000001131" } }, { "@type": "ScholarlyArticle", "name": "Eligibility for Human Leukocyte Antigen-Based Therapeutics by Race and Ethnicity.", "datePublished": "2023-10-02", "url": "https://questionsmedicales.fr/article/37883087", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2023.38612" } }, { "@type": "ScholarlyArticle", "name": "Human Leukocyte Antigen-DQ Genotyping in Pediatric Celiac Disease.", "datePublished": "2023-01-10", "url": "https://questionsmedicales.fr/article/36816433", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5223/pghn.2023.26.1.50" } }, { "@type": "ScholarlyArticle", "name": "How to measure human leukocyte antigen-specific B cells.", "datePublished": "2023-08-18", "url": "https://questionsmedicales.fr/article/37678170", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MOT.0000000000001097" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Personnes", "item": "https://questionsmedicales.fr/mesh/D009272" }, { "@type": "ListItem", "position": 3, "name": "Esclaves", "item": "https://questionsmedicales.fr/mesh/D063948" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Esclaves - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Esclaves", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Esclaves", "description": "Comment identifier une personne esclave ?\nQuels tests peuvent aider au diagnostic ?\nQuels signes physiques peuvent indiquer l'esclavage ?\nComment évaluer le traumatisme psychologique ?\nQuels professionnels peuvent diagnostiquer l'esclavage ?", "url": "https://questionsmedicales.fr/mesh/D063948?mesh_terms=Leukocyte+L1+Antigen+Complex&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Esclaves", "description": "Quels symptômes psychologiques sont fréquents ?\nQuels symptômes physiques peuvent apparaître ?\nComment l'esclavage affecte-t-il la santé mentale ?\nY a-t-il des symptômes de stress post-traumatique ?\nQuels comportements peuvent être observés ?", "url": "https://questionsmedicales.fr/mesh/D063948?mesh_terms=Leukocyte+L1+Antigen+Complex&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Esclaves", "description": "Comment prévenir l'esclavage moderne ?\nQuel rôle jouent les gouvernements ?\nComment les ONG contribuent-elles à la prévention ?\nPourquoi l'éducation est-elle cruciale ?\nComment les entreprises peuvent-elles aider ?", "url": "https://questionsmedicales.fr/mesh/D063948?mesh_terms=Leukocyte+L1+Antigen+Complex&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Esclaves", "description": "Quels traitements psychologiques sont recommandés ?\nComment traiter les blessures physiques ?\nY a-t-il des médicaments pour les symptômes ?\nQuel rôle joue le soutien communautaire ?\nComment les groupes de soutien peuvent-ils aider ?", "url": "https://questionsmedicales.fr/mesh/D063948?mesh_terms=Leukocyte+L1+Antigen+Complex&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Esclaves", "description": "Quelles sont les complications psychologiques ?\nY a-t-il des complications physiques ?\nComment l'esclavage affecte-t-il les relations sociales ?\nQuelles sont les conséquences économiques ?\nComment l'esclavage impacte-t-il la famille ?", "url": "https://questionsmedicales.fr/mesh/D063948?mesh_terms=Leukocyte+L1+Antigen+Complex&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Esclaves", "description": "Quels sont les facteurs de risque socio-économiques ?\nComment la migration influence-t-elle le risque ?\nQuels groupes sont plus à risque ?\nQuel rôle joue la culture dans le risque d'esclavage ?\nComment les conflits armés affectent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D063948?mesh_terms=Leukocyte+L1+Antigen+Complex&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier une personne esclave ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'identification repose sur des signes de contrainte, isolement et absence de liberté." } }, { "@type": "Question", "name": "Quels tests peuvent aider au diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des entretiens, évaluations psychologiques et observations des conditions de vie sont utiles." } }, { "@type": "Question", "name": "Quels signes physiques peuvent indiquer l'esclavage ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des blessures, malnutrition et signes de négligence sont souvent observés." } }, { "@type": "Question", "name": "Comment évaluer le traumatisme psychologique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des outils d'évaluation standardisés peuvent mesurer l'impact psychologique de l'esclavage." } }, { "@type": "Question", "name": "Quels professionnels peuvent diagnostiquer l'esclavage ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs sociaux, psychologues et médecins sont souvent impliqués dans le diagnostic." } }, { "@type": "Question", "name": "Quels symptômes psychologiques sont fréquents ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Anxiété, dépression et stress post-traumatique sont courants chez les esclaves." } }, { "@type": "Question", "name": "Quels symptômes physiques peuvent apparaître ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue chronique, douleurs corporelles et troubles alimentaires sont souvent signalés." } }, { "@type": "Question", "name": "Comment l'esclavage affecte-t-il la santé mentale ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "L'esclavage peut entraîner des troubles mentaux graves, y compris des troubles de l'humeur." } }, { "@type": "Question", "name": "Y a-t-il des symptômes de stress post-traumatique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, flashbacks, cauchemars et évitement de situations rappelant l'esclavage sont fréquents." } }, { "@type": "Question", "name": "Quels comportements peuvent être observés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Isolement social, méfiance et comportements autodestructeurs peuvent être présents." } }, { "@type": "Question", "name": "Comment prévenir l'esclavage moderne ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation, la sensibilisation et des lois strictes sont essentielles pour prévenir l'esclavage." } }, { "@type": "Question", "name": "Quel rôle jouent les gouvernements ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les gouvernements doivent adopter des lois et politiques pour protéger les droits humains." } }, { "@type": "Question", "name": "Comment les ONG contribuent-elles à la prévention ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les ONG sensibilisent, soutiennent les victimes et plaident pour des changements législatifs." } }, { "@type": "Question", "name": "Pourquoi l'éducation est-elle cruciale ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation aide à sensibiliser les populations aux dangers de l'esclavage et à ses signes." } }, { "@type": "Question", "name": "Comment les entreprises peuvent-elles aider ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les entreprises doivent adopter des pratiques éthiques et surveiller leurs chaînes d'approvisionnement." } }, { "@type": "Question", "name": "Quels traitements psychologiques sont recommandés ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie cognitivo-comportementale et le soutien psychologique sont efficaces." } }, { "@type": "Question", "name": "Comment traiter les blessures physiques ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les soins médicaux appropriés, y compris la réhabilitation physique, sont essentiels." } }, { "@type": "Question", "name": "Y a-t-il des médicaments pour les symptômes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des antidépresseurs et anxiolytiques peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "Quel rôle joue le soutien communautaire ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Le soutien communautaire aide à la réintégration et à la guérison des victimes." } }, { "@type": "Question", "name": "Comment les groupes de soutien peuvent-ils aider ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les groupes de soutien offrent un espace sécurisé pour partager des expériences et guérir." } }, { "@type": "Question", "name": "Quelles sont les complications psychologiques ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les victimes peuvent souffrir de troubles mentaux persistants, comme la dépression chronique." } }, { "@type": "Question", "name": "Y a-t-il des complications physiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies chroniques, blessures non traitées et problèmes de santé peuvent survenir." } }, { "@type": "Question", "name": "Comment l'esclavage affecte-t-il les relations sociales ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les victimes peuvent éprouver des difficultés à établir des relations saines après l'esclavage." } }, { "@type": "Question", "name": "Quelles sont les conséquences économiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les victimes peuvent avoir des difficultés à trouver un emploi et à subvenir à leurs besoins." } }, { "@type": "Question", "name": "Comment l'esclavage impacte-t-il la famille ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les familles peuvent être déchirées, et les enfants peuvent souffrir de traumatismes." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque socio-économiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "La pauvreté, le manque d'éducation et l'instabilité politique augmentent le risque d'esclavage." } }, { "@type": "Question", "name": "Comment la migration influence-t-elle le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les migrants sont souvent vulnérables à l'exploitation et à l'esclavage en raison de leur statut." } }, { "@type": "Question", "name": "Quels groupes sont plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les femmes, les enfants et les minorités ethniques sont souvent plus exposés à l'esclavage." } }, { "@type": "Question", "name": "Quel rôle joue la culture dans le risque d'esclavage ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines cultures peuvent normaliser l'exploitation, augmentant ainsi le risque d'esclavage." } }, { "@type": "Question", "name": "Comment les conflits armés affectent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Les conflits créent des conditions propices à l'esclavage, en augmentant la vulnérabilité des populations." } } ] } ] }

Sources (10000 au total)

Advances in desensitization for human leukocyte antigen incompatible kidney transplantation.

Human leukocyte antigen (HLA) sensitization is a major barrier to kidney transplantation induced by exposure to alloantigens through pregnancy, blood product exposure and previous transplantations. De... Newer desensitization strategies such as imlifidase [immunoglobulin G (IgG) endopeptidase] rapidly inactivates IgG molecules and creates an "antibody-free zone", representing an important advancement ... Use of these agents alone or in combination will likely improve the efficacy and durability of desensitization therapies, improving access to kidney transplantation for immunologically disadvantaged p...

Eligibility for Human Leukocyte Antigen-Based Therapeutics by Race and Ethnicity.

The development of therapeutics for patients who are positive for specific human leukocyte antigen (HLA) subtypes evokes the question of whether certain racial and ethnic groups are more or less likel... To determine whether racial and ethnic inequities were present with regard to trial eligibility in trials investigating a therapeutic restricted to patients with specific HLA subtypes.... This cross-sectional study included all clinical trials registered in ClinicalTrials.gov through March 18, 2022, that investigated an interventional study of a therapeutic strategy and restricted part... The type of therapeutics used in trials, the condition under study, the HLA subtypes used, and the likelihood of being enrolled in such a trial according to race and ethnicity.... Of 2135 trials identified, 263 met inclusion criteria. Overall, the estimated likelihood of being eligible for an HLA-based trial was 50.3%. Individuals of African American descent had the lowest like... The findings of this cross-sectional study suggest that enrollment restrictions for clinical trials investigating novel HLA therapeutics may be associated with racial and ethnic inequities with regard...

Human Leukocyte Antigen-DQ Genotyping in Pediatric Celiac Disease.

The purpose of this study was to determine the pattern of human leukocyte antigen (HLA)-DQ genotype in children diagnosed with celiac disease (CD) (biopsy proven), and to compare this with a control g... This cross-sectional comparative observational study included 26 controls and 52 patients diagnosed with CD who presented at Sir Padampat Mother and Child Health Institute, Jaipur, from May, 2017 to O... HLA DQ2/DQ8 genotypes were significantly more common in CD (present in 100.0% cases) than in controls (23.1%) in Northern India (Rajasthan). When HLA DQ2.5 and DQ8 were present together, individuals h... HLA DQ2/DQ8 genotypes are strongly associated with pediatric CD patients in northern India. These genotypes and their combinations may be associated with different clinical presentations of CD, and ma...

How to measure human leukocyte antigen-specific B cells.

The implementation of highly sensitive immune assays measuring anti-human leukocyte antigen (HLA) antibodies has modified alloimmune risk stratification and diagnosis of rejection. Nonetheless, anti-H... Functional assays involving ex vivo polyclonal activation of mBC have been refined to allow the detection of HLA-specific mBC capable of producing anti-HLA Abs, using different and complementary detec... Technological refinements have allowed the development of tests detecting HLA-specific mBC. Further evaluation of these assays in clinical trials, both for immune risk stratification and to assess tre...

Heart Transplant Human Leukocyte Antigen Matching in the Modern Era.

Although numerous reports have studied the consequences of human leukocyte antigen (HLA) mismatching in renal transplantation, there are limited and outdated data analyzing this association in thoraci... We performed a retrospective analysis of adult patients after heart transplant by using the United Network for Organ Sharing database from January 2005-July 2021. Total HLA and HLA-A, HLA-B and HLA-DR... A total of 33,060 patients were included in this study. Recipients with a high degree of HLA mismatching had increased incidences of acute organ rejection. There were no significant differences in mor... Our analysis suggests that HLA mismatch is not a significant predictor of survival in the modern era. Overall, the clinical implications of this study provide reassuring data for the continued use of ...

Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response.

Since the beginning of the anti-COVID-19 vaccination campaign, it has become evident that vaccinated subjects exhibit considerable inter-individual variability in the response to the vaccine that coul... We carried out a genome-wide association study to investigate the genetic determinants of the antibody response to the Pfizer-BioNTech vaccine in an Italian cohort of 1351 subjects recruited in three ... Our study confirms the involvement of the HLA locus and shows significant associations with variants in HLA-A, HLA-DQA1, and HLA-DQB1 genes. In particular, the HLA-A*03:01 allele is the most significa... These results support the hypothesis that HLA genes modulate the response to Pfizer-BioNTech vaccine and highlight the need for genetic studies in diverse populations and for functional studies aimed ...

Association study of human leukocyte antigen variants and idiopathic pulmonary fibrosis.

Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia marked by progressive lung fibrosis and a poor prognosis. Recent studies have highlighted the potential role of infection in the... We performed a meta-analysis of associations of the HLA region with IPF risk in individuals of European ancestry from seven independent case-control studies of IPF (comprising 5159 cases and 27 459 co... The meta-analysis of all seven studies identified four significant independent single nucleotide polymorphisms associated with IPF risk. However, none met the posterior probability for replication cri... Variation in the HLA region was not consistently associated with risk in studies of IPF. However, this does not preclude the possibility that other genomic regions linked to the immune response may be...

Loss of Human Leukocyte Antigen and Immune Escape in Head and Neck Cancer.

Cancer cells evade recognition by the immune system to survive. Head and neck squamous cell carcinoma (HNSCC) is characterized by high levels of immune infiltration and mutation-associated neoantigens... Cross-sectional integrated clinical and genomic analysis.... Whole-exome sequencing and RNA-sequencing data from 522 tumors profiled in The Cancer Genome Atlas HNSCC cohort were analyzed and integrated with secondary analyses including immune cell deconvolution... HLA LOH was a prevalent event that was identified in 53% of HNSCC tumors; in many cases, more than one class I HLA gene was targeted for LOH. HLA LOH was more common in advanced-stage tumors. Tumors w... HLA LOH is one of the most prevalent genetic alterations in HNSCC, and is associated with a cold immune microenvironment, suggesting that HLA LOH is a means of immune evasion. It may have value as a p... 3 Laryngoscope, 2023....